Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Santhanaraman, Narendran"'
Publikováno v:
Journal of Clinical and Translational Research
Background: Nimotuzumab is a monoclonal antibody against epidermal growth factor receptor which can be combined with chemotherapy and radiotherapy for the treatment of locally advanced unresectable squamous cell carcinoma of head-and-neck region and
Autor:
Nagarajan A; Department of Radiation Oncology, Cancer institute, Adyar, Chennai, Tamil Nadu, India., Sakthivelu A; Department of Radiation Oncology, Cancer institute, Adyar, Chennai, Tamil Nadu, India., Santhanaraman N; Department of Radiation Oncology, Cancer institute, Adyar, Chennai, Tamil Nadu, India., Ravichandar R; Assistant Professor, Department of Pharmacology, Sree Balaji Medical College and Hospital, Chennai, India.
Publikováno v:
Journal of clinical and translational research [J Clin Transl Res] 2021 Mar 16; Vol. 7 (2), pp. 285-288. Date of Electronic Publication: 2021 Mar 16 (Print Publication: 2021).